Esketamine nasal spray, FDA-approved since 2019 for treatment-resistant depression - taken in our clinic, under a doctor's supervision, with your progress measured at every visit.
Fewer than two trials? The screener will say "not yet" - and the doctor letter makes your next prescription count toward qualifying.
Quick symptom measures and blood pressure. Same nurse, same questions, so change is visible week to week.
You administer the nasal spray yourself, with the clinician right there. No IVs, no needles.
A comfortable chair, dim light if you want it, vitals checked on schedule. Doze, listen to music, or just be.
Someone you trust drives you home. The FDA label is explicit: no driving until the next day, and only after a restful sleep.
With commercial insurance, the manufacturer's savings program (Spravato withMe) can bring your cost to as little as $10 per treatment - up to an annual limit.
The limit, stated plainly: the program covers up to $8,150 in eligible out-of-pocket costs per calendar year, and that amount resets every January 1. Once you reach it, you pay your plan's normal cost-share for the rest of that year. We open October 1, so a course that starts this year has three months against this year's limit before the new year's limit begins. We put your projected numbers, including where the limit lands for you, in writing before your first treatment.
By law the program can't be combined with Medicaid, Medicare, or TRICARE - for those plans we work the coverage directly, and patient costs are typically minimal.
Whatever your plan, you get your exact numbers in writing before your first treatment. No surprise bills. Ever.
The screener routes you honestly - clinic, at-home, or “not yet.”
Start the 2-minute screenerBook a consultThe clinic opens October 1, 2026 - we are booking consults now. A real person calls you back within one business day.